Stock listing

TSX:APS Aptose Biosciences Inc Stock

Follow Aptose Biosciences Inc into a list and get an email when it puts out news.

Delisted TSX:APS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
TSX:APS
Asset type
Stock
Exchange
TSX
Currency
CAD

What changed lately

Latest news

All Aptose Biosciences Inc news

Aptose Biosciences Inc on 6ix

News releases
11 in the last 12 months · 49 in all · newest Jun 30, 2026 · oldest 2010
Calls
14 calls with a replay · 14 with a transcript · latest May 14, 2024
Decks
7 decks · latest Mar 12, 2025

Where Aptose Biosciences Inc is listed

ListingExchangeCountryCurrency
TSX:APS · This page · DelistedTSXCanadaCAD
NASDAQ:APTO · DelistedNASDAQUnited StatesUSD

Events

CallWhenStatus
Aptose Biosciences (APTO) Q1 2024 Earnings CallTue, May 14, 2024 · 5:00 PM ETReplay
Aptose Biosciences (APTO) Q4 2023 Earnings CallTue, Mar 26, 2024 · 5:00 PM ETReplay
Aptose Biosciences (APTO) Q3 2023 Earnings CallThu, Nov 09, 2023 · 5:00 PM ETReplay
Aptose Biosciences (APTO) Q2 2023 Earnings CallThu, Aug 10, 2023 · 5:00 PM ETReplay
Aptose Biosciences (APTO) Q1 2023 Earnings CallMon, May 08, 2023 · 5:00 PM ETReplay
Aptose Biosciences (APTO) Q4 2022 Earnings CallThu, Mar 23, 2023 · 5:00 PM ETReplay
Aptose Biosciences (APTO) Q3 2022 Earnings CallTue, Nov 01, 2022 · 5:00 PM ETReplay
Aptose Biosciences (APTO) Q2 2022 Earnings CallTue, Aug 02, 2022 · 5:00 PM ETReplay
Aptose Biosciences (APTO) Q1 2022 Earnings CallMon, May 09, 2022 · 5:00 PM ETReplay
Aptose Biosciences (APTO) Q4 2021 Earnings CallTue, Mar 22, 2022 · 5:00 PM ETReplay
All 14 calls
CallWhenStatus
Aptose Biosciences (APTO) Q3 2021 Earnings CallThu, Nov 11, 2021 · 5:00 PM ETReplay
Aptose Biosciences (APTO) Q2 2021 Earnings CallTue, Aug 03, 2021 · 5:00 PM ETReplay
Aptose Biosciences (APTO) Q1 2021 Earnings CallTue, May 04, 2021 · 4:30 PM ETReplay
Aptose Biosciences (APTO) Q3 2020 Earnings CallTue, Nov 10, 2020 · 5:00 PM ETReplay

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (March 2025)Investor deck23 slidesMar 12, 2025
Investor Presentation (January 2025)Investor deck20 slidesJan 13, 2025
Investor Presentation (July 2024)Investor deck20 slidesJul 26, 2024
Investor Presentation (January 2023)Investor deck36 slidesJan 6, 2023
Investor Presentation (July 2022)Investor deck25 slidesJul 20, 2022
Investor Presentation (June 2022)Investor deck44 slidesJun 27, 2022
Investor Presentation (July 2018)Investor deck30 slidesJul 9, 2018

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Caroline M Loewy
Other companies: eFFECTOR Therapeutics Inc (Director · Sep 9, 2023 – Jun 13, 2024 · Past); CERo Therapeutics Holdings, Inc. (Director · Oct 5, 2021 – Feb 14, 2024 · Past); Zogenix Inc (Director · Sep 21, 2020 – Mar 7, 2022 · Past); PhaseBio Pharmaceuticals Inc (Director · Oct 17, 2018 – May 19, 2023 · Past)
Director · Dec 21, 2018 – Jan 18, 2022 · Past
Bernd R. Seizinger
Other companies: Oncolytics Biotech Inc. (Director · Since at least Jan 1, 2026); Aprea Therapeutics, Inc. (Director · Since at least Oct 2, 2019)
Director · Sep 13, 2022 – Feb 5, 2024 · Past
Denis R Burger
Other companies: CytoDyn Inc. (Director · Feb 7, 2014 – Jul 12, 2018 · Past); Sarepta Therapeutics, Inc. (Chief Executive Officer, Director · Feb 16, 2006 – Apr 3, 2007 · Past)
Director · Dec 21, 2018 – Feb 5, 2024 · Past
Jotin Marango
Other companies: ImageneBio, Inc. (Chief Financial Officer · Since at least Apr 25, 2022)
Senior VP, CFO, and CBO · Jun 3, 2019 – Jan 18, 2022 · Past
Brian UnderdownUntil Jan 20, 2015 · Past
Erich PlatzerDirector · Dec 15, 2014 – Feb 5, 2024 · Past
Philippe LedruSr VP & Ch Commerical Officer · Feb 5, 2024 – Feb 5, 2024 · Past
Rafael BejarSr VP & Chief Medical Officer · Jan 4, 2021 – Feb 5, 2024 · Past
Warren WhiteheadDirector · Dec 21, 2018 – Feb 5, 2024 · Past
William G RiceChair, President & CEO, Director · Since at least Jan 4, 2021

Open People

Log in to ask 6ix AI your own questions about Aptose Biosciences Inc.